"The Li family is lucky, and I survived this time." Hu Chi disappeared for a few days, and when he appeared again, he looked like he had survived the disaster.

Yang Rui wanted to laugh when he heard this, so he slowly soaked tea and said, "The winter for the old and slow-witted patients is the most difficult, but as long as he gets through it, it will last another year."

"Yes, the coldest time has passed, and there should be no more changes in the future." Hu Chi drank tea, praised, and said, "Can the cost of making medicine be lowered? This year will be next."

Mr. Li will be Mr. Wang after him. Comrade Hu Chi naturally doesn’t need to say that.

Yang Rui said indifferently: "Yes, there are expensive methods, and there are poor methods."

He is not perfunctory either. Although there is no new drug development in China now, on the one hand, there is huge risks, and on the other hand, the regulations are relatively backward and there is no motivation to develop new drugs.

Most companies ultimately have to face the local and domestic markets.

For Chinese companies, the primary goal of R&D is to solve the problem of domestic drug use. Domestic medical policies are far less complex and high requirements than those of Europe and the United States.

For the same clinical trial, all steps can be basically eliminated in China. Chinese medicine and patent medicine do not even need double-blindness, so what other clinical trials are needed.

In this context, domestic companies mainly do not have the experience in developing new drugs, which leads to the failure of a new drug.

In contrast, Yang Rui, who has worked in ferrotone in the past, has already had more experience in the research and development of new drugs.

If necessary, he can guide researchers to develop new drugs without having to do it himself.

If the funding is small, it is not impossible to develop new drugs with second-hand instruments and low-end instruments.

It’s just that the success rate is the first.

If you don’t want to waste time from researchers in the Ion Channel Laboratory, Yang Rui can even hire temporary employees.

Hu Chi is now familiar with Yang Rui's speech pattern, but he asks with great vigilance: "How poor?"

"It's a poor way." Yang Rui pondered for a moment and said, "The sixty or seventy million US dollars need to be prepared. If it's less, it's 50 million US dollars. If it's less, it's vain to do the wrong two directions, and then it's a waste."

Yang Rui was not intentionally exaggerating. Even if he could see the direction clearly, he didn't know how long it took to do the experiment.

Hu Chi curled his lips and said, "Who can give out 50 million at this time? It's still US dollars."

Yang Rui shrugged and said, "I will also be able to do the second phase of the clinical trial. If you are willing to hand over the subsequent part to a foreign company, you can do it for $30 million, which is similar to the cost of the drug for Gaucher disease I am making now. Of course, it is possible to not be able to produce glucetalysine enzymes for $30 million, but as long as you make something and show hope, Jielikan should still be willing to add the cost."

"We don't have the money to add more costs."

"us?"

Hu Chi coughed twice and said, "Mr. Li is also the old revolutionary of that year. In short, 30 million US dollars is still too much."

"Then there is nothing to do, this is the price of poverty."

"Can you talk to Jielikan? Let them join in and work together?" Hu Chi obviously did his homework. All he wanted was a new drug. Although everyone didn't even talk about what new drug it was, he always subconsciously thought that the new drug would be good.

From this perspective, it seems that it doesn’t matter if you introduce foreign companies. It not only saves initial investment funds, but also gets the medicine you want. The so-called market exchange technology is also the case.

However, drugs for mass chronic diseases are not areas that are easy to conquer as rare diseases.

Even multinational companies like Jilikon have to be careful in this field. In history, more than one case of investing $500 million in cost and falling into the quagmire.

There are more than one or two Nobel Prize winners fighting in this field.

Yang Rui smiled and said, "You can try it with Jielikang. Before the enzyme of glucetapeta enzyme is launched, it may be difficult for them to extract energy and use a more complex drug."

Hu Chi had no momentum and said, "You can't even talk about it, let alone us."

However, Hu Chi did not give up completely. After taking a few sips of tea, he said, "Aren't you doing the project you are doing now a little bit? In two years, letting Lao Li's family get you a little more, and you may not suffer any loss."

Yang Rui smiled and said, "I'll wait until you see the price of instruments and equipment tomorrow, so you won't say that."

He was talking about the procurement delegation that was about to set out.

"Okay..." Hu Chi had no say in the professional field, but in terms of his experience, foreigners' instruments and equipment are indeed outrageously expensive.

However, neither Yang Rui nor Hu Chi expected that after the news of the procurement delegation spread, it caused another trend.

It is not a trivial thing for the industry to form a group to go abroad for procurement.

There is already a need to replace and purchase materials, so it goes without saying that even central enterprises and large state-owned enterprises that had no plans have begun to find relationships.

When Yang Rui returned home, he only arrived at the entrance of the alley and was stopped by several state-owned enterprise leaders from private banks.

It is very difficult to hide your address in China. Unless you are a little person who is not concerned, there will always be a day when it will be leaked.

Yang Rui had a banquet in his house and had long expected it, but in the past, officials liked to stop at the door of the laboratory, and it was rare for them to stop at the door of the house.

"Director Yang."

"Professor Yang..."

Several state-owned enterprise leaders greeted each other, but they were not from the same group.

Yang Rui really wanted to shoot a candle and ask, "What's the matter?"

"Professor Yang, I heard you are going to organize a procurement delegation to go to Europe to do procurement?" An official took the initiative to express his intentions. He was standing by the empress dowager and greeted him too far.

Yang Rui nodded and said, "There is such a thing, but it is not my organization. It should be the lead of the Chemical Medicine Revitalization Office or other institutions."

"No matter which department it is, you must have the final say." The official smiled and said a compliment, and said: "Professor Yang, our Siyou Company is a medical machinery production company directly under the ministries and commissions. We have long wanted to update the production line. Look, can we join your delegation this time."

"It's useless for you to find me..."

"No need for the delegation's quota, we can just follow us. Just take the time to give me some advice. Please, please." After saying that, the man stuffed a business card into Yang Rui's hand, put a pack of gifts on the ground, and turned around and left.

When the others saw it, let's do it. Anyway, everyone has no friendship, so they rely on sincerity to speak.

In a moment, a gift surrounded Yang Rui into a circle, and his hands were filled with business cards.

"Wait, wait." Yang Rui grabbed the smaller one and said, "Don't have a delegation quota, what does it mean to follow?"

Seeing that Yang Rui really didn't know, the small leader said naturally: "The delegation must be short, and we don't expect to get it. We just bring the money to buy tickets and go with you. At that time, if you can give me some advice, I'll be very grateful."

Yang Rui thought about it for a while before he realized that the quota of the delegation was probably controlled by Hu Chi. The activities organized by the Chemistry and Medicine Revitalization Office were also the money paid by the Chemistry and Medicine Revitalization Office, so they naturally took the big shot.

If it is a large enterprise such as a central enterprise, the leaders probably went to public relations for Hu Chi and came to Yang Rui to find all of them.

If you say that Chinese companies are pitiful, they don’t know much about the language, and they have little understanding of the world trade system, and they don’t know much about professional knowledge.

In the era when many companies have no college students, it is still very likely to say that the employees of the company can know the latest equipment status. Even through some foreign information research institutes, it is difficult to understand comprehensively.

Of course, in more cases, various research institutes are simply too lazy to pay attention to such companies.

Being able to act with Nobel Prize winners is obviously an economical choice for them.

However, the size of this delegation is difficult to control.
Chapter completed!